tiprankstipranks
Trending News
More News >
Benson Hill, Inc. (BHIL)
NASDAQ:BHIL
US Market
Advertisement

Benson Hill (BHIL) AI Stock Analysis

Compare
109 Followers

Top Page

BH

Benson Hill

(NASDAQ:BHIL)

Rating:39Underperform
Price Target:
Benson Hill's stock score reflects significant financial challenges, including declining revenues and high leverage, which are the primary concerns. The technical analysis does not show signs of recovery, and the negative valuation metrics further contribute to the low score. Improvements in cash flow management are noted but are insufficient to offset the broader financial instability.

Benson Hill (BHIL) vs. SPDR S&P 500 ETF (SPY)

Benson Hill Business Overview & Revenue Model

Company DescriptionBenson Hill (BHIL) is an innovative food technology company that operates at the intersection of plant biology, data science, and food production. The company is focused on advancing food production systems by leveraging its CropOS platform, a cutting-edge computational platform that combines machine learning and genomics to improve crop performance. Benson Hill aims to deliver more nutritious, sustainable, and affordable food solutions by optimizing the growth and production of plants and plant-based ingredients.
How the Company Makes MoneyBenson Hill generates revenue primarily through its proprietary CropOS platform and its associated plant breeding and biotechnology services. The company earns money by developing and licensing improved crop varieties, which are designed to enhance yield, nutritional content, and sustainability. Additionally, Benson Hill partners with agricultural companies, food manufacturers, and ingredient suppliers to co-develop tailored crop solutions. Revenue streams also include direct sales of seeds and plant-based ingredients to food producers and processors. Strategic partnerships and collaborations with industry leaders further bolster its financial performance by expanding market reach and accelerating innovation.

Benson Hill Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
BreakdownTTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income Statement
Total Revenue205.82M473.34M381.23M147.21M59.07M79.52M
Gross Profit10.36M23.63M3.53M-945.00K4.65M8.56M
EBITDA-57.48M-54.27M-55.36M-109.09M-46.80M-39.91M
Net Income-101.77M-115.31M-127.91M-126.25M-64.52M-43.91M
Balance Sheet
Total Assets137.54M274.76M500.92M534.90M231.78M96.74M
Cash, Cash Equivalents and Short-Term Investments14.41M48.68M157.17M182.65M110.08M10.93M
Total Debt94.40M145.83M187.64M165.73M65.42M18.70M
Total Liabilities110.70M188.72M307.02M283.45M99.10M45.04M
Stockholders Equity26.84M86.04M193.90M251.45M132.68M51.70M
Cash Flow
Free Cash Flow-40.20M-84.89M-109.88M-149.24M-62.53M-51.19M
Operating Cash Flow-38.02M-73.13M-93.40M-117.75M-52.68M-44.35M
Investing Cash Flow131.46M118.03M-40.25M-154.59M-100.67M-4.55M
Financing Cash Flow-119.08M-72.14M98.01M341.56M160.70M48.55M

Benson Hill Risk Analysis

Benson Hill disclosed 59 risk factors in its most recent earnings report. Benson Hill reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Benson Hill Peers Comparison

Overall Rating
UnderperformOutperform
Sector (44)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$7.73B63.4521.52%30.93%11.78%
ADADM
66
Neutral
$26.13B19.396.03%3.81%-8.59%-50.72%
58
Neutral
$2.05B-83.81%-19.85%4.94%
54
Neutral
$6.53B-1.16%4.88%-196.93%
44
Neutral
C$961.63M-6.69-13.73%2.46%17.55%-32.57%
39
Underperform
$367.45K-141.52%-54.24%23.84%
32
Underperform
$475.87K-43.11%-26.70%27.53%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BHIL
Benson Hill
0.06
-6.44
-99.08%
ADM
Archer Daniels Midland
54.39
-7.29
-11.82%
CORT
Corcept Therapeutics
70.86
36.29
104.98%
PLUG
Plug Power
1.79
-0.71
-28.40%
RGEN
Repligen
116.25
-13.33
-10.29%
DNMRQ
Danimer Scientific
0.15
-22.89
-99.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―